CARDIOVASC RES 润色咨询

CARDIOVASCULAR RESEARCH

出版年份：1967 年文章数：2609 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：12.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2017-09-01 陈梅斯

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2017-07-16 zheyang

    还是5分多,虽然没有大变化,能稳定在些,也算是中上等

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2017-01-19 tsirea

    这个杂志心血管临床方面的研究可以投吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-10-23 佩珀

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。
    感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。
    要屡败屡战，不相信攻克不了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-10-21 qqd140d1b8

    被拒了，6天

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-10-15 qqd140d1b8

    刚投了一篇，等消息，我来试试看

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-09-19 jyzxjiangqin

    没有考虑过投稿。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-09-14 青龙偃月

    还没有投稿过，求指教

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-09-13 青龙偃月

    还没有发过，求指教

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=546169, encodeId=abf05461690d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2015年12月28号投稿.2016年1月7号拒稿(可再投),3月23号再投.4月30日出结果denovo.8月5号再投.9月21号小修.9月26号再投.11月1号第2次小修.11月15号第3次小修.12月26号accept.待会再来讲详细过程., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf82006167, createdName=陈梅斯, createdTime=Fri Sep 01 12:22:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544218, encodeId=7a0654421867, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532046, encodeId=2c8d532046e0, content=这个杂志心血管临床方面的研究可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8361948122, createdName=tsirea, createdTime=Thu Jan 19 10:41:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528542, encodeId=0ad652854202, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被拒了一篇，8号提交，11号收到信说细胞系不够明确，要求补充后重新提交，14号再次提交后，21号被拒。没有机会外审，主编认为实验方法欠缺。 <br> 感觉越来越难投的杂志，11年，审稿20天悲剧，13年审稿60天悲剧，16年7天悲剧。 <br> 要屡败屡战，不相信攻克不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ce1b1970028, createdName=佩珀, createdTime=Sun Oct 23 12:07:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528471, encodeId=ea035284e143, content=被拒了，6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Fri Oct 21 07:41:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528242, encodeId=5bfe528242e8, content=刚投了一篇，等消息，我来试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Oct 15 08:20:00 CST 2016, time=2016-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527318, encodeId=f73b52e31801, content=没有考虑过投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Sep 19 06:37:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527153, encodeId=aaed52e15336, content=还没有投稿过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 14 09:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527098, encodeId=995b52e0986a, content=还没有发过，求指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Tue Sep 13 09:01:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526728, encodeId=67bd526e28c4, content=不敢去投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Sep 03 06:37:00 CST 2016, time=2016-09-03, status=1, ipAttribution=)]
    2016-09-03 jyzxjiangqin

    不敢去投稿。

    0

共116条页码: 4/12页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分